Publication:
Successful Treatment of Verruca Plantaris with a Single Sublesional Injection of Interferon-α2a

dc.authorscopusid57218912537
dc.authorscopusid59157762600
dc.authorscopusid7801356412
dc.authorscopusid55341256300
dc.contributor.authorAksakal, A.A.
dc.contributor.authorÖzden, Müge Güler
dc.contributor.authorAtahan, C.
dc.contributor.authorÖnder, M.
dc.date.accessioned2020-06-21T15:07:48Z
dc.date.available2020-06-21T15:07:48Z
dc.date.issued2009
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Aksakal] A. A., Department of Dermatology, Gazi University, Faculty of Medicine, Ankara, Turkey; [Özden] Müge Güler, Department of Dermatology, Gazi University, Faculty of Medicine, Ankara, Turkey; [Atahan] Çiǧdem Asena, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Önder] Meltem, Department of Dermatology, Gazi University, Faculty of Medicine, Ankara, Turkeyen_US
dc.description.abstractBackground. Interferons are molecules with antiviral effects, which have been used for the treatment of verruca for many years. Aims. To determine if sublesional interferon (IFN)-α injection offers an effective alternative treatment for common warts. Methods. We compared the results of single-dose sublesional IFN application in different types of verruca and with placebo for the treatment of single verruca plantaris lesions. In total, 53 patients (mean age 22.6 years) were enrolled in the study. Of these, 45 patients received a single sublesional injection of 4.5 MU IFN-α2a (three study groups), and eight patients with single verruca plantaris lesions were injected with physiological saline as placebo (control group). As local anaesthesia, liquid nitrogen was sprayed only on to the injection site for 3-4 s. The injection was made directly under the lesion through the border of the lesion, at with approximately a 45° angle from healthy skin. Results. At the 12-month follow-up in the group of patients with single verruca plantaris, there were 19 complete cures (7.2%) and 2 partial responses (8.3%), and 3 patients (12.5%) had no response. In the control group, only 2 patients (25%) had a partial response to treatment. Conclusions. These results suggest that a single sublesional dose of 4.5 MU IFN-α may be of value in the treatment of patients with verruca, especially in those with single verruca plantaris lesions. © 2008 The Author(s).en_US
dc.identifier.doi10.1111/j.1365-2230.2008.02924.x
dc.identifier.endpage19en_US
dc.identifier.issn0307-6938
dc.identifier.issn1365-2230
dc.identifier.issue1en_US
dc.identifier.pmid19076790
dc.identifier.scopus2-s2.0-57349183231
dc.identifier.scopusqualityQ2
dc.identifier.startpage16en_US
dc.identifier.urihttps://doi.org/10.1111/j.1365-2230.2008.02924.x
dc.identifier.urihttps://hdl.handle.net/20.500.12712/18884
dc.identifier.volume34en_US
dc.identifier.wosWOS:000261519700003
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherWiley-Blackwell Publishing, Incen_US
dc.relation.ispartofClinical and Experimental Dermatologyen_US
dc.relation.journalClinical and Experimental Dermatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSuccessful Treatment of Verruca Plantaris with a Single Sublesional Injection of Interferon-α2aen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files